IBM (NYSE:IBM | IBM Price Prediction) currently trades at $212.67, while the average Wall Street price target sits at $273.75, leaving a gap of roughly 29% between current levels and analyst consensus.
That gap widened sharply this week. IBM runs the mainframes, hybrid cloud stack, and consulting practice most Fortune 500 companies depend on. Wall Street had treated it as a durable AI beneficiary through Red Hat and watsonx, making the past few trading sessions a shock.
Wedbush’s Dan Ives maintains a $350 target that implies more than 64% upside, roughly double consensus.
A Preannounced Miss Triggered the Worst Session Since 1968
IBM plunged more than 26% in one week after management preannounced Q2 results well below consensus. CEO Arvind Krishna attributed the shortfall to customers redirecting IT budgets toward AI servers and memory amid a global shortage, with additional pressure from the z17 mainframe program launch.
The reaction was severe. IBM had beaten estimates for four consecutive quarters, and trailing free cash flow for Q1 2026 had softened to $2.22 billion, down 44.15% year over year. A Wall Street Zen downgrade to sell accelerated the selling.
Software peers Salesforce and ServiceNow sold off alongside IBM on the same news, while semiconductor names rallied.
Why Ives and Most of the Street Are Not Blinking
The bull thesis treats this as an execution stumble, not structural decay. Ives views IBM as a core holding on his “IVES AI 30” list and is betting the Q2 miss is isolated rather than evidence of lost enterprise AI runway anchored by watsonx, automated AI agents, and consulting. Wedbush has chosen to freeze active adjustments and hold the $350 line until the formal Q2 call on July 22.
Fundamentals support this view. IBM Z mainframe revenue grew 51% year over year in Q1 2026, and the generative AI book of business crossed $12.5 billion inception-to-date by Q4 2025. Management reaffirmed FY2026 guidance for more than 5% constant currency revenue growth and roughly $1 billion of free cash flow improvement.
The sell side remains constructive. Alpha Vantage’s tracker shows 3 Strong Buy, 12 Buy, 7 Hold, 0 Sell, and 1 Strong Sell ratings across 23 analysts. With implied upside north of 40% to the Ives call, the July 22 earnings report is the next real test.
How the Enterprise IT Peer Group Compares
The peer set diverged sharply. IBM and Oracle got crushed, Accenture is deep in a bear market, and HPE rallied on AI networking demand.
Oracle (NYSE:ORCL) trades at $126.41 after a 30.88% one-month drawdown, versus a $251.85 average target. That is nearly 99% implied upside with a 8 Strong Buy, 29 Buy, 5 Hold, 1 Sell posture. It carries the largest analyst-implied gap in the group.
Accenture (NYSE:ACN) sits at $143.57, down 45.07% year to date, against a $179.13 target, implying roughly 25% upside. Ratings tilt neutral at 2 Strong Buy, 12 Buy, and 13 Hold, with recent revisions trimming rather than raising.
Hewlett Packard Enterprise (NYSE:HPE) is the outlier, up 92.46% year to date at $45.82, versus a $64.13 target for about 40% upside. Ratings sit at 4 Strong Buy, 8 Buy, 10 Hold.
Oracle carries the widest upside, but IBM’s setup is cleaner: less capex burn, an existing free cash flow machine, and a target reflecting a return toward its $332.46 52-week high rather than uncharted territory.
IBM’s Current Valuation and Setup
IBM trades at $212.67 with a market cap of roughly $200 billion. Consensus $273.75 target across 23 analysts implies about 29% upside, while Ives’ $350 print target pushes that to roughly 65%. The stock is down 27.26% year to date, against a 9% gain for the S&P 500 over the same window.
Valuation looks reasonable at a forward P/E of 17, backed by a 3.07% dividend yield and a 31st consecutive year of dividend increases. Polymarket is pricing 82.6% odds of an earnings miss on July 22.
The Path Forward
The bull case strengthens if the July 22 call reframes the preannouncement as a mainframe timing issue rather than lost enterprise wallet share, if Krishna reaffirms the $1 billion FCF improvement and 5%+ constant currency growth, and if the AI book of business shows sequential improvement. That path gets the stock toward $273 and gives Ives’ $350 legitimate runway.
The bear case strengthens if consulting growth stalls further, if memory-driven capex crowding-out proves durable through FY2027, and if shrinking free cash flow becomes the trend. A dividend aristocrat with weakening cash generation is how a value trap starts. The setup looks cautiously constructive at these levels, though the July 22 earnings report remains the key catalyst to watch.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks